JBT Marel Earnings Call Highlights Growth, Tariff Risks

Jbt Marel Corporation ((JBTM)) has held its Q4 earnings call. Read on for the main highlights of the call.

JBT Marel Corporation’s latest earnings call struck a confident tone as management emphasized better‑than‑expected revenue, early EPS accretion, and strong synergy delivery. Executives acknowledged tariff-driven cost pressure and a Q4 margin dip, but framed these as manageable headwinds against a backdrop of healthy demand, rapid deleveraging, and ambitious 2026 profit targets.

Order Strength Underpins Growth Visibility

Full‑year orders reached $3.8 billion, including more than $1.0 billion in a strong fourth quarter, giving investors comfort on future revenue conversion. Management highlighted accelerating order synergies, with $30 million captured for 2025, more than half booked in Q4, and expected to flow meaningfully into revenue in 2026.

Revenue Beats Guidance With FX Tailwind

The combined company generated $3.8 billion in 2025 revenue, topping the high end of prior guidance and underscoring solid execution post‑transaction. Currency also provided a boost, with favorable foreign exchange translation adding $77 million to the top line for the year.

Margin Expansion and Solid EBITDA Performance

JBT Marel posted adjusted EBITDA of $600 million, implying a 15.8% margin that landed at the midpoint of its guided range and signaled healthy profitability. In Q4, the adjusted EBITDA margin ticked up to 16.0%, while segment margins were even stronger, with Protein Solutions at 20.1% and Prepared Food & Beverage at 17.2%.

First-Year EPS Accretion Delivered

Adjusted EPS came in at $6.41, marking clear accretion in the first year of the combined business and beating the legacy JBT baseline of $6.15 from 2024. That roughly 4.2% uplift confirms management’s integration promises are translating into tangible earnings benefit for shareholders.

Deleveraging Accelerates Balance Sheet Repair

The company made notable progress reducing leverage from just under 4.0x at deal closing to below 2.9x by the end of 2025, easing balance sheet concerns. Management now targets leverage of roughly 2.0–2.5x by late 2026, supported by strong cash generation and convertible financing already in place.

Synergies Tracking Ahead of Long-Term Targets

Integration synergies are ramping quickly, with $43 million of year‑over‑year benefit realized in 2025 and about $85 million of run‑rate savings exiting the year versus a 2024 baseline. The company reiterated confidence in achieving $150 million of run‑rate synergies by the end of 2027 and expects about $60 million of incremental synergy gain in 2026.

Poultry-Led End-Market Momentum

Demand trends were particularly strong in poultry equipment, which management described as the dominant growth engine across categories amid a sharp recovery in customer investment. The company also cited solid trends in meat, beverages, and pharma, alongside improving Prepared Foods orders that showed better traction in the fourth quarter.

Tariffs Weigh on Margins but Are Manageable

Tariff costs that began ramping in April 2025 cut deeply into profitability, totaling about $43 million for the year even after $15 million of cost avoidance actions. These duties shaved roughly 50 basis points off adjusted EBITDA margin, and management expects about $45 million of tariff cost in 2026 before pricing and mitigation efforts.

Q4 Margin Dip Reflects Investment for 2026

The Q4 adjusted EBITDA margin of 16% declined sequentially, as incremental tariff pressure and growth investments hit the P&L at the same time. Management framed the margin softness as a deliberate choice to fund resources and capacity needed to support the higher revenue and earnings expected in 2026.

Operational Hiccups in Prepared Foods and AGV

Prepared Food & Beverage operations, especially automated guided vehicles, experienced inefficiencies that weighed on fourth‑quarter profitability and execution. Leadership expects these issues to be largely addressed by the end of the first quarter of 2026, with some limited carryover into early second quarter.

Costly Supply-Chain Regionalization in Motion

To reduce long‑term exposure to tariffs and geopolitical risk, JBT Marel is shifting more suppliers and manufacturing toward the U.S. and other regional hubs. This multi‑year restructuring will demand significant execution through at least 2027 and offers little near‑term relief against current tariff headwinds.

Policy Uncertainty Clouds Tariff Outlook

Management emphasized that shifting tariff rules and recent legal developments create a moving target for both cost planning and commercial pricing. This uncertainty complicates the timing and scale of mitigation measures, forcing the company to maintain flexibility in its strategy for passing through costs or reshaping its footprint.

Guidance Signals Confident 2026 Upside

For 2026, JBT Marel guided to 5%–7% revenue growth, including about a 1% currency tailwind, and adjusted EBITDA margins of 17.0%–17.5%, roughly 145 basis points higher at the midpoint. Adjusted EPS is projected at $8.00–$8.50, with GAAP EPS of $4.70–$5.15, supported by about $60 million in incremental synergies and partially offset by roughly $45 million in tariff costs before mitigation.

The earnings call painted a picture of a company executing well on integration and growth plans despite a tough tariff backdrop and temporary operational bumps. For investors, the key takeaway is that strong demand, rising synergies, and rapid deleveraging are building a platform for meaningful EPS growth into 2026, even as cost and policy risks remain in focus.